Literature DB >> 10713027

Giant cell myocarditis responding to immunosuppressive therapy.

A Frustaci1, C Chimenti, M Pieroni, N Gentiloni.   

Abstract

An unusual case of giant cell myocarditis presenting with cardiogenic shock that dramatically responded to conventional dose of steroids and azathioprine is reported. Cardiac recovery was rapid, complete (left ventricular ejection fraction rose to 55% from 10%), and was accompanied by the disappearance of the inflammatory infiltrates including giant cells in the control endomyocardial biopsy. Maintenance of the recovery at 16 months of follow-up on a low dose of azathioprine suggests that giant cell myocarditis might be a heterogeneous disease having either a negative untreatable trend necessitating cardiac transplantation, or a curable substrate responding to immunosuppressive drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713027     DOI: 10.1378/chest.117.3.905

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Vascular involvement in cardiac giant cell myocarditis: a new pathophysiological aspect.

Authors:  S Elezkurtaj; D Lassner; H-P Schultheiss; F Escher
Journal:  Clin Res Cardiol       Date:  2013-11-20       Impact factor: 5.460

Review 2.  Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy.

Authors:  B Maisch; S Pankuweit
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

Review 3.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

4.  Support with the BVS 5000 assist device during treatment of acute giant-cell myocarditis.

Authors:  Daniel Marelli; Reza Kermani; Jessica Bresson; Michael C Fishbein; Michele Hamilton; Jaime Moriguchi; Gregg C Fonarow; Benjamin Cohen; Jon Kobashigawa; Hillel Laks
Journal:  Tex Heart Inst J       Date:  2003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.